Interferon signalling and non-canonical inflammasome activation promote host protection against multidrug-resistant Acinetobacter baumannii

G Burgio, FJ Li, L Starrs, A Mathur, DE Tuipulotu… - 2024 - researchsquare.com
Multidrug-resistant (MDR) Acinetobacter baumannii are of major concern worldwide due to
their resistance to last resort carbapenem and polymyxin antibiotics. To develop an effective …

GBP1 promotes killing of multidrug-resistantAcinetobacter baumanniiand promotes host protection via interferon signalling and inflammasome activation

F Li, L Starrs, A Mathur, SM Man, G Burgio - 2022 - europepmc.org
Multidrug resistant (MDR) Acinetobacter baumannii are of major concern worldwide due to
their resistance to last resort carbapenem and polymyxin antibiotics. To develop an effective …

GBP1 promotes killing of multidrug-resistant Acinetobacter baumannii and promotes host protection via interferon signalling and inflammasome activation

FJ Li, L Starrs, A Mathur, D Enosi Tuipulotu, SM Man… - bioRxiv, 2022 - biorxiv.org
Multidrug resistant (MDR) Acinetobacter baumannii are of major concern worldwide due to
their resistance to last resort carbapenem and polymyxin antibiotics. To develop an effective …

[HTML][HTML] NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection

N Dikshit, SD Kale, HJ Khameneh, V Balamuralidhar… - Mucosal …, 2018 - Elsevier
The opportunistic Gram-negative bacterium Acinetobacter baumannii (AB) is a leading
cause of life-threatening nosocomial pneumonia. Outbreaks of multidrug resistant (MDR)-AB …

Differential activation of NLRP3 inflammasome by Acinetobacter baumannii strains

FJ Li, L Starrs, A Mathur, H Ishii, SM Man, G Burgio - Plos one, 2022 - journals.plos.org
Acinetobacter baumannii is an emerging nosocomial, opportunistic pathogen with growing
clinical significance globally. A. baumannii has an exceptional ability to rapidly develop drug …

Guanylate-binding protein-dependent noncanonical inflammasome activation prevents Burkholderia thailandensis-induced multinucleated giant cell formation

M Dilucca, S Ramos, K Shkarina, JC Santos, P Broz - Mbio, 2021 - Am Soc Microbiol
Inflammasomes are cytosolic multiprotein signaling complexes that are activated upon
pattern recognition receptor-mediated recognition of pathogen-derived ligands or …

NLRP3 inflammasome mediates interleukin‐1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in …

MJ Kang, SG Jo, DJ Kim, JH Park - Immunology, 2017 - Wiley Online Library
Acinetobacter baumannii is a multi‐drug resistant, Gram‐negative bacteria and infection
with this organism is one of the major causes of mortality in intensive care units …

Caspase-11 plays a protective role in pulmonary Acinetobacter baumannii infection

W Wang, Y Shao, S Li, N Xin, T Ma, C Zhao… - Infection and …, 2017 - Am Soc Microbiol
Activation of caspase-11 by some Gram-negative bacteria triggers the caspase-1/interleukin
1β (IL-1β) pathway, independent of canonical inflammasomes. Acinetobacter baumannii is a …

[PDF][PDF] Detrimental type I interferon signaling dominates protective AIM2 inflammasome responses during Francisella novicida infection

Q Zhu, SM Man, R Karki, RKS Malireddi… - Cell reports, 2018 - cell.com
Interferons (IFNs) and inflammasomes are essential mediators of anti-microbial immunity.
Type I IFN signaling drives activation of the AIM2 inflammasome in macrophages; however …

Outer membrane protein A inhibits the degradation of caspase-1 to regulate NLRP3 inflammasome activation and exacerbate the Acinetobacter baumannii pulmonary …

Y Li, C Peng, D Zhao, L Liu, B Guo, M Shi, Y Xiao… - Microbial …, 2021 - Elsevier
Abstract Acinetobacter baumannii (A. baumannii), one of the major pathogens that causes
severe nosocomial infections, is characterised by a high prevalence of drug resistance. It …